Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
spacer.gif (43 bytes)
February 6,  2002

Hologic's Advisory Committee on Women's Health Voices Strong Disagreement with PDQ Announcement on Screening Mammography


 (SafetyAlerts) - Hologic, Inc. (NASDAQ: HOLX) , responding to a recent announcement from Physician Data Query (PDQ) questioning the benefits of screening mammography on breast cancer mortality rates, today released the following statement from its Advisory Committee on Women's Health:

"We strongly disagree with PDQ's findings and question the comprehensiveness of their evaluation," said Georgia Hitzke, Chairwoman of the Committee and Hologic's Vice President of Clinical Services. "Their findings were based entirely on a single highly contested meta-analysis of several studies with recognized flaws, without reference to numerous well-controlled clinical studies that support the benefits of screening mammography. It is to be hoped that women and healthcare providers will view this announcement with skepticism and that women will continue to have routine screening mammograms, as recommended by the American Cancer Society and the National Cancer Institute (NCI)."

The PDQ editorial board, an independent panel consisting of experts both in and outside of the NCI, is responsible for maintaining and updating cancer information summaries on NCI's website. NCI does not anticipate changing its current recommendation for screening mammography without additional information and a "deliberative and meticulous process." NCI recommends women 40 and older have a screening mammogram every year or two. The American Cancer Society found no evidence in PDQ's announcement to support a change in its recommendation that women 40 and older have a screening mammogram every year.

Hologic's Advisory Committee on Women's Health, composed of Hologic employees and external medical professionals, was formed to provide recommendations for enhancing Hologic's focus on women's imaging issues, particularly in the areas of breast cancer and osteoporosis, and to ensure that current healthcare considerations in these areas are incorporated into strategic directives for the Company.

According to Ms. Hitzke, "The independent clinical advisors that sit on Hologic's Advisory Committee on Women's Health, along with the majority of healthcare professionals, recognize that screening mammography is an essential component of women's preventative healthcare. It is not disputed that screening mammography identifies cancers earlier than they would otherwise be found. With what is known regarding the relationship between tumor size, nodal spread and prognosis, it is counterintuitive to think that finding a smaller cancer will not save some women from dying of breast cancer. We hope PDQ will augment its evaluation of this issue by studying the results of more recent, well-controlled clinical trials and by analyzing the correlation between the increase in screening mammograms and declining mortality rates from breast cancer since 1990."

The American College of Radiology and a consortium of healthcare associations have also issued statements refuting the findings of PDQ and the studies on which the findings were based. More information regarding these statements can be found at

Source: PRNewswire.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.